Your browser is no longer supported. Please, upgrade your browser.
Settings
MCK McKesson Corporation daily Stock Chart
MCK [NYSE]
McKesson Corporation
IndexS&P 500 P/E8.19 EPS (ttm)21.11 Insider Own3.11% Shs Outstand210.21M Perf Week4.04%
Market Cap36.36B Forward P/E13.18 EPS next Y13.12 Insider Trans-10.80% Shs Float208.22M Perf Month8.12%
Income4.54B PEG2.27 EPS next Q2.93 Inst Own91.50% Short Float3.16% Perf Quarter15.34%
Sales201.96B P/S0.18 EPS this Y137.00% Inst Trans0.10% Short Ratio3.09 Perf Half Y4.24%
Book/sh53.32 P/B3.24 EPS next Y7.42% ROA7.40% Target Price177.64 Perf Year15.09%
Cash/sh12.19 P/C14.19 EPS next 5Y3.61% ROE44.00% 52W Range133.82 - 173.88 Perf YTD10.91%
Dividend1.36 P/FCF13.22 EPS past 5Y33.50% ROI27.90% 52W High-1.73% Beta1.24
Dividend %0.79% Quick Ratio0.60 Sales past 5Y10.20% Gross Margin5.40% 52W Low27.69% ATR3.61
Employees78000 Current Ratio1.10 Sales Q/Q4.20% Oper. Margin3.20% RSI (14)68.45 Volatility2.18% 2.02%
OptionableYes Debt/Eq0.75 EPS Q/Q-99.60% Profit Margin2.20% Rel Volume0.60 Prev Close172.96
ShortableYes LT Debt/Eq0.67 EarningsFeb 01 BMO Payout5.30% Avg Volume2.13M Price170.88
Recom2.60 SMA205.35% SMA5011.14% SMA20011.77% Volume681,127 Change-1.20%
Jan-23-18Reiterated Needham Buy $173 → $180
Jan-05-18Initiated Evercore ISI Outperform
Dec-04-17Initiated Deutsche Bank Buy $175
Nov-01-17Reiterated Needham Buy $178 → $173
Oct-25-17Reiterated Needham Buy $179 → $178
Sep-19-17Upgrade Robert W. Baird Neutral → Outperform $175 → $178
Sep-19-17Initiated RBC Capital Mkts Sector Perform $168
Sep-14-17Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-08-17Upgrade Needham Hold → Buy $179
May-30-17Reiterated Mizuho Neutral $147 → $168
May-23-17Upgrade JP Morgan Neutral → Overweight
May-19-17Reiterated UBS Neutral $145 → $156
May-17-17Resumed Jefferies Hold $153
Apr-04-17Initiated Needham Hold
Jan-18-17Upgrade Avondale Mkt Perform → Mkt Outperform
Jan-05-17Downgrade JP Morgan Overweight → Neutral $169
Jan-03-17Downgrade Mizuho Buy → Neutral $147
Nov-23-16Downgrade Credit Suisse Neutral → Underperform
Nov-11-16Downgrade Standpoint Research Buy → Hold
Nov-09-16Upgrade Mizuho Neutral → Buy $147
Jan-22-18 12:51PM  Kentucky accuses McKesson of helping fuel opioid epidemic Reuters
11:55AM  Kentucky accuses McKesson of helping fuel opioid epidemic Reuters
Jan-19-18 07:00AM  Selling Drugs Is Harder Than It Looks Morningstar
Jan-18-18 03:00AM  Mckesson Earns Relative Strength Rating Upgrade Investor's Business Daily
Jan-17-18 08:09AM  5 Reasons Why McKesson Deserves a Place in Your Portfolio Zacks
12:01AM  Walmart Takes on the Opioid Crisis With a New Tool That Destroys Drugs Fortune
Jan-16-18 06:00AM  10 Cheap Stocks With Growing Dividends Morningstar
Jan-15-18 03:45PM  From drug pricing and 'biosimilars' to opioids and culture a wrap and podcast from biotech's big conference American City Business Journals
Jan-11-18 08:00AM  See what the IHS Markit Score report has to say about McKesson Corp. Markit
Jan-09-18 04:40PM  McKesson CEO: Claims that company ignored opioid crisis are 'nonsense' (Video) American City Business Journals
04:09PM  Judge urges action on '100 percent manmade' opioid crisis Associated Press
02:58PM  McKesson CEO: It's 'Nonsense' We Haven't Done Enough to Combat Opioid Crisis TheStreet.com
12:02PM  UPDATE: McKesson Technologies in Alpharetta awarded $400M DOD health imaging contract American City Business Journals
Jan-08-18 11:39PM  McKesson CEO Hammergren Weighs in on Tech Giants Eyeing Pharma Bloomberg Video
11:37PM  McKesson CEO: 'Nonsense' That We Ignored Opioid Crisis Bloomberg Video
11:20PM  McKesson Corp. CEO on Opioid Epidemic and Tech's Role in Pharmaceuticals Bloomberg Video
Jan-07-18 07:18AM  America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear TheStreet.com
Jan-06-18 12:00PM  A Controversial Pick of the Year for 2018 TheStreet.com
Jan-04-18 05:44PM  McKesson Buys RxCrossroads from CVS Health for $735 Million Zacks
04:10PM  McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled for February 1, 2018 Business Wire
Jan-03-18 09:52PM  Rite Aid Corporation (RAD) Q3 2018 Earnings Conference Call Transcript Motley Fool
09:00AM  McKesson Completes Acquisition of RxCrossroads Business Wire
Jan-01-18 09:04AM  BD Advances Medication Management Business through Innovations Market Realist
Dec-29-17 03:04PM  Year in Review: CoverMyMeds $1.3B acquisition biggest tech and M&A story of 2017 American City Business Journals
Dec-27-17 09:00AM  12 Fabulous Fortune Reads From 2017 Fortune
Dec-26-17 09:06AM  The Zacks Analyst Blog Highlights: Wal-Mart, Procter & Gamble, NVIDIA, Cigna and McKesson Zacks
Dec-19-17 04:10PM  McKesson Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference Business Wire
01:01AM  Denver-based DEA opioid probe of McKesson was 'hijacked,' says Washington Post-'60 Minutes' report American City Business Journals
Dec-18-17 10:15PM  Mckesson Corp (MCK) Chairman, President & CEO John H Hammergren Sold $10.4 million of Shares GuruFocus.com
04:51PM  Amplify Snack Brands and Akamai soar while McKesson slips Associated Press
01:02PM  Opioid Crisis: McKesson Corporation Stock Drops After 60 Minutes Report InvestorPlace
12:26PM  TODAY'S CHARTS: Twitter gets an upgrade; Hershey and Campbell bet big on snacks Yahoo Finance
09:26AM  McKesson CFO James Beer to leave to join Atlassian MarketWatch
09:00AM  McKesson Announces Departure of James Beer, EVP and CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook Business Wire
Dec-16-17 05:55PM  How Did McKesson Corporations (NYSE:MCK) 39.56% ROE Fare Against The Industry? Simply Wall St.
Dec-15-17 05:19PM  McKesson unit wins $400 mln U.S. defense contract -Pentagon Reuters
Dec-11-17 12:10PM  10 Energizer Bunny Stocks Forbes
Dec-08-17 11:28AM  Secret McKesson Records Show Failed Opioid Oversight, Suit Says Bloomberg
Dec-04-17 10:12AM  McKesson Corp. : MCK-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 4, 2017 Capital Cube
08:01AM  See what the IHS Markit Score report has to say about McKesson Corp. Markit
Dec-03-17 10:01AM  Financial Advisors: 5 Best Stock Investing Ideas For 2018 Forbes
Dec-01-17 08:49AM  Amazon Pharma Business Rumors Are Making Drug Stocks Go Crazy Fortune
06:56AM  Amazon in Exploratory Talks with Generic-Drug Makers: Report Investopedia
Nov-28-17 08:00AM  Free Post Earnings Research Report: McKesson's Revenue Grew 4%; Adjusted EPS Advanced 11% ACCESSWIRE
Nov-23-17 09:00AM  Top 10 Largest Pharmaceutical Companies By Revenue in 2017 Insider Monkey
Nov-21-17 05:54AM  McKesson Gains From Distribution Business Amid Pricing Woes Zacks
Nov-20-17 10:58AM  Cardinal Health, McKesson decline after declared by Morgan Stanley as most at risk in case of Amazon entry MarketWatch
Nov-17-17 07:35AM  New Research Coverage Highlights Zions, McKesson, Sealed Air, CenterPoint Energy, Coca-Cola European Partners, and KKR & Co. Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-16-17 09:40AM  See what the IHS Markit Score report has to say about McKesson Corp. Markit
Nov-14-17 02:05PM  Here's what the biggest hedge funds have been buying and selling Yahoo Finance
07:18AM  Amazon Will Not Store or Ship Drugs: Report Investopedia
Nov-13-17 12:44PM  ETFs with exposure to McKesson Corp. : November 13, 2017 Capital Cube
Nov-07-17 08:28AM  McKesson Targets Specialty Pharma Growth with Deal for CVS's RxCrossroads TheStreet.com
07:23AM  McKesson (MCK) to Acquire RxCrossroads for $735 Million Zacks
Nov-06-17 05:37PM  Drug distributor McKesson to buy CVS Health's services unit Reuters
05:05PM  McKesson to buy RXCrossroads from CVS for $735 million MarketWatch
04:25PM  Drug distributor McKesson to buy CVS Health's unit for $735 mln Reuters
04:16PM  McKesson Strengthens Its Portfolio of Manufacturer Solutions with the Acquisition of RxCrossroads Business Wire
08:04AM  States Focus On Incentives Of Wholesalers And Pharmacies In Drug Price-Fixing Probe Forbes
Nov-03-17 04:00PM  Chuck Norris sues med-tech companies, including one in Twin Cities American City Business Journals
Nov-01-17 04:44PM  Ohio AG gives McKesson, others 30 days to be 'part of the solution' on addictive opioids American City Business Journals
12:22PM  ETFs with exposure to McKesson Corp. : November 1, 2017 Capital Cube
09:02AM  BG Staffing And Other Great Cheap Stocks Simply Wall St.
Oct-31-17 07:45PM  Missouri attorney general demands opioid distributor records Associated Press
Oct-30-17 12:30PM  Amazon Pharmacy Threat Forbes
09:38AM  McKesson Corp. :MCK-US: Earnings Analysis: Q2, 2018 By the Numbers : October 30, 2017 Capital Cube
Oct-27-17 03:05PM  Amazon.com Takes Aim at Drug Prices Motley Fool -5.52%
08:01AM  See what the IHS Markit Score report has to say about McKesson Corp. Markit
Oct-26-17 07:41PM  Edited Transcript of MCK earnings conference call or presentation 26-Oct-17 12:00pm GMT Thomson Reuters StreetEvents -5.18%
04:24PM  Markets Right Now: Technology, banks lead rebound Associated Press
03:30PM  New Mexico sues pharma companies & drug distributors CNBC Videos
12:53PM  McKesson Fights Back With Strong Earnings, Revenue Gains Motley Fool
10:49AM  Lawsuits Won't Fix Opioid Epidemic, Top Drug Distributor Says Bloomberg
09:20AM  McKesson (MCK) Beats Earnings & Revenue Estimates in Q2 Zacks
08:31AM  McKesson (MCK) Beats on Earnings and Sales in Q2 Zacks
08:09AM  McKesson shares rise on Q2 profit, revenue beats MarketWatch
07:31AM  Drug distributor McKesson's quarterly profit beats estimates Reuters
07:25AM  McKesson beats Street 2Q forecasts Associated Press
07:10AM  Drug distributor McKesson's qtrly profit plunges on charges Reuters
07:00AM  McKesson Reports Fiscal 2018 Second-Quarter Results Business Wire
Oct-25-17 09:52AM  MedTech Stock Q3 Earnings Roster for Oct 26: BSX, RMD & More Zacks
08:40AM  Should You Buy McKesson Corporation (MCK) Ahead of Earnings? Zacks
Oct-23-17 08:06AM  McKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : October 23, 2017 Capital Cube
07:05AM  Mckesson (MCK) to Report Q2 Earnings: A Beat in the Cards? Zacks
Oct-18-17 11:02AM  The Intrinsic Value Of McKesson Corp Forbes
08:00AM  See what the IHS Markit Score report has to say about McKesson Corp. Markit
Oct-17-17 04:10PM  McKesson Corporation to Present at the 26th Annual Credit Suisse Healthcare Conference Business Wire
10:00AM  3 Dividend Healthcare Stocks Motley Fool
Oct-16-17 06:57PM  Is There Now An Opportunity In McKesson Corporation (MCK)? Simply Wall St.
09:29AM  DEA Whistleblower Blasts Drug Distributors, Congress Over Opioid Collusion Fortune
Oct-09-17 08:28AM  McKesson Corp. breached its 50 day moving average in a Bearish Manner : MCK-US : October 9, 2017 Capital Cube
Oct-06-17 08:10PM  Motiwala Capital Investor Letter: Why Small Fund Finds These Five Stocks Undervalued Insider Monkey
Oct-05-17 04:10PM  McKesson Corporation Fiscal 2018 Second Quarter Conference Call Scheduled for October 26, 2017 Business Wire
Oct-02-17 09:55AM  Is McKesson (MCK) a Great Stock for Value Investors? Zacks
Sep-30-17 12:15AM  Mckesson Corp (MCK) Chairman, President & CEO John H Hammergren Sold $30.6 million of Shares GuruFocus.com
Sep-29-17 04:54PM  Insiders Roundup: Twitter, McKesson Make Biggest Trades GuruFocus.com
09:37AM  Does McKesson Corporations (MCK) PE Ratio Signal A Buying Opportunity? Simply Wall St.
08:11AM  McKesson Corp. breached its 50 day moving average in a Bearish Manner : MCK-US : September 29, 2017 Capital Cube
Sep-28-17 01:30PM  This $300 Billion Amazon Rumor Just Won't Die Investor's Business Daily
12:15AM  Mckesson Corp (MCK) Chairman, President & CEO John H Hammergren Sold $46.4 million of Shares GuruFocus.com
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAMMERGREN JOHN HChairman, President & CEODec 14Sale160.0065,00010,400,0000Dec 18 08:34 PM
McElligott Kathleen D.EVP, CIO & CTONov 01Option Exercise0.0078401,487Nov 02 06:20 PM
HAMMERGREN JOHN HChairman, President & CEOSep 29Option Exercise87.2499,0008,636,760164,000Sep 29 09:14 PM
HAMMERGREN JOHN HChairman, President & CEOSep 29Sale153.8999,00015,234,97165,000Sep 29 09:14 PM
HAMMERGREN JOHN HChairman, President & CEOSep 28Option Exercise87.24100,0008,724,000165,000Sep 29 09:14 PM
HAMMERGREN JOHN HChairman, President & CEOSep 28Sale153.51100,00015,350,79065,000Sep 29 09:14 PM
HAMMERGREN JOHN HChairman, President & CEOSep 27Option Exercise87.20100,0008,720,270164,000Sep 27 09:13 PM
HAMMERGREN JOHN HChairman, President & CEOSep 27Sale155.30100,00015,529,73065,000Sep 27 09:13 PM
HAMMERGREN JOHN HChairman, President & CEOSep 26Option Exercise83.51100,0008,351,000165,000Sep 27 09:13 PM
HAMMERGREN JOHN HChairman, President & CEOSep 26Sale154.81100,00015,481,47065,000Sep 27 09:13 PM
HAMMERGREN JOHN HChairman, President & CEOSep 25Option Exercise83.51100,0008,351,000165,000Sep 27 09:13 PM
HAMMERGREN JOHN HChairman, President & CEOSep 25Sale154.15100,00015,415,10065,000Sep 27 09:13 PM
HAMMERGREN JOHN HChairman, President & CEOSep 22Option Exercise83.51100,0008,351,000165,000Sep 22 09:30 PM
HAMMERGREN JOHN HChairman, President & CEOSep 22Sale153.53100,00015,352,60065,000Sep 22 09:30 PM
HAMMERGREN JOHN HChairman, President & CEOSep 20Sale150.18125,00018,772,500400,256Sep 22 09:30 PM
Lampert Erin MSVP & ControllerSep 07Sale155.65900140,0891,413Sep 08 05:25 PM
JACOBS M CHRISTINEDirectorAug 21Sale145.431,083157,5000Aug 22 04:47 PM
KNOWLES MARIE L/CADirectorJul 31Sale162.551,083176,0420Aug 01 05:23 PM
HAMMERGREN JOHN HChairman, President & CEOJun 01Sale164.9519,3093,185,0810Jun 01 06:35 PM
HAMMERGREN JOHN HChairman, President & CEOMay 31Sale162.5719,3103,139,17319,309Jun 01 06:35 PM
Lampert Erin MSVP & ControllerMay 31Sale160.66809129,97459Jun 01 05:59 PM
Lampert Erin MSVP & ControllerMay 30Sale160.5340464,854868May 31 06:37 PM
HAMMERGREN JOHN HChairman, President & CEOMay 30Sale162.3119,3163,135,09938,619May 31 06:31 PM
HAMMERGREN JOHN HChairman, President & CEOMay 27Option Exercise0.0096,644096,644May 31 06:31 PM
JULIAN PAUL CEVP, Group PresidentMay 27Option Exercise0.0053,428053,485May 31 06:06 PM
Figueredo JorgeEVP, Human ResourcesMay 27Option Exercise0.0015,688023,661May 31 05:58 PM
BEER JAMES AEVP & Chief Financial OfficerMay 27Option Exercise0.0012,059027,539May 31 05:47 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerMay 27Option Exercise0.001,89801,898May 31 05:36 PM
Lampert Erin MSVP & ControllerMay 27Option Exercise0.001,94402,003May 31 06:37 PM
Lampert Erin MSVP & ControllerMay 24Option Exercise0.0096096May 25 05:46 PM
HAMMERGREN JOHN HChairman, President & CEOMar 29Option Exercise67.8178,1105,296,63978,110Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 29Sale150.5678,11011,760,5380Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 28Option Exercise67.8122,3901,518,26622,390Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 28Sale150.0122,3903,358,7870Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 02Option Exercise67.8142,6002,888,70642,600Mar 03 04:36 PM
HAMMERGREN JOHN HChairman, President & CEOMar 02Sale150.4242,6006,407,9260Mar 03 04:36 PM
HAMMERGREN JOHN HChairman, President & CEOMar 01Option Exercise67.8157,9003,926,19957,900Mar 03 04:36 PM
HAMMERGREN JOHN HChairman, President & CEOMar 01Sale150.5557,9008,716,5960Mar 03 04:36 PM